Dyne Therapeutics (DYN)
(Delayed Data from NSDQ)
$36.59 USD
+0.18 (0.49%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $36.54 -0.05 (-0.14%) 7:58 PM ET
3-Hold of 5 3
C Value C Growth D Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/4/24 |
---|---|
Current Quarter | -0.71 |
EPS Last Quarter | -0.70 |
Last EPS Surprise | 2.78% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -2.96 |
Next Year | -3.07 |
EPS (TTM) | -3.59 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.71 | -0.74 | -2.96 | -3.07 |
# of Estimates | 8 | 8 | 9 | 9 |
Most Recent Consensus | -0.77 | -0.78 | -2.91 | -2.81 |
High Estimate | -0.60 | -0.63 | -2.75 | -2.29 |
Low Estimate | -0.80 | -0.85 | -3.16 | -3.49 |
Year ago EPS | -0.99 | -1.09 | -3.95 | -2.96 |
Year over Year Growth Est. | 28.28% | 32.11% | 25.06% | -3.68% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 5 | 3 | 4 | 4 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 2 | 4 | 4 | 4 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.71 | -0.74 | -2.96 | -3.07 |
7 Days Ago | -0.71 | -0.74 | -2.96 | -3.07 |
30 Days Ago | -0.71 | -0.74 | -2.96 | -3.07 |
60 Days Ago | -0.74 | -0.75 | -3.00 | -3.06 |
90 Days Ago | -0.74 | -0.75 | -3.00 | -3.06 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.71 | -0.74 | -2.96 | -3.07 |
Zacks Consensus Estimate | -0.71 | -0.74 | -2.96 | -3.07 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.70 | -0.81 | -1.09 | -0.99 | NA |
Estimate | -0.72 | -0.81 | -0.92 | -0.86 | NA |
Difference | 0.02 | 0.00 | -0.17 | -0.13 | -0.07 |
Surprise | 2.78% | 0.00% | -18.48% | -15.12% | -7.71% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more